Alerts will be sent to your verified email
Verify Email
FGP
|
FGP
|
Sterling Internl.Ent
|
Vanta Bioscience
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.05 % | n/a | -9.14 % |
|
5yr Avg Net Profit Margin
|
61.47 % | n/a | -22.86 % |
|
Price to Book
|
3.29 | n/a | 0.0 |
|
P/E
|
0.0 | n/a | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | n/a | -2109.35 Days |
|
5yr Average Interest Coverage Ratio
|
-1325.47 | n/a | 0.56 |
|
5yr Avg ROCE
|
-3.44 % | n/a | 1.17 % |
|
5yr Avg Operating Profit Margin
|
-329.83 % | n/a | 16.63 % |
|
5 yr average Debt to Equity
|
0.0 | n/a | 2.28 |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
1.08 % | n/a | -1.51 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.45 % | n/a | 69.36 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | n/a | -0.57 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
FGP
|
Sterling Internl.Ent
|
Vanta Bioscience
|
|---|